ZA929268B - Imidazole compounds, their preparation and use. - Google Patents

Imidazole compounds, their preparation and use.

Info

Publication number
ZA929268B
ZA929268B ZA929268A ZA929268A ZA929268B ZA 929268 B ZA929268 B ZA 929268B ZA 929268 A ZA929268 A ZA 929268A ZA 929268 A ZA929268 A ZA 929268A ZA 929268 B ZA929268 B ZA 929268B
Authority
ZA
South Africa
Prior art keywords
alkyl
preparation
imidazole compounds
alkoxy
halogen
Prior art date
Application number
ZA929268A
Other languages
English (en)
Inventor
Oskar Axelsson
Mikkel Thaning
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of ZA929268B publication Critical patent/ZA929268B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Lubricants (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Dental Preparations (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
ZA929268A 1991-12-03 1992-11-30 Imidazole compounds, their preparation and use. ZA929268B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80175491A 1991-12-03 1991-12-03

Publications (1)

Publication Number Publication Date
ZA929268B true ZA929268B (en) 1993-06-29

Family

ID=25181970

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929268A ZA929268B (en) 1991-12-03 1992-11-30 Imidazole compounds, their preparation and use.

Country Status (15)

Country Link
US (1) US5314903A (ko)
EP (1) EP0545845B1 (ko)
JP (1) JPH072796A (ko)
KR (1) KR100220303B1 (ko)
AT (1) ATE134622T1 (ko)
AU (1) AU649899B2 (ko)
CA (1) CA2084233A1 (ko)
DE (1) DE69208604T2 (ko)
DK (1) DK0545845T3 (ko)
ES (1) ES2084972T3 (ko)
FI (1) FI925501A (ko)
GR (1) GR3019439T3 (ko)
NO (1) NO300832B1 (ko)
NZ (1) NZ245287A (ko)
ZA (1) ZA929268B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154092D0 (da) * 1992-12-23 1992-12-23 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU4768999A (en) * 1998-07-02 2000-01-24 Neurosearch A/S Potassium channel blocking agents
US6194447B1 (en) 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
AU760250B2 (en) 1998-12-04 2003-05-08 Neurosearch A/S New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
WO2004064835A1 (en) * 2003-01-17 2004-08-05 Neurosearch A/S Use of ion channel modulating agents for treating pain
US20060135506A1 (en) * 2003-04-22 2006-06-22 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
WO2004093816A2 (en) * 2003-04-22 2004-11-04 Pharmacia Corporation Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
WO2005007124A2 (en) 2003-07-23 2005-01-27 Bristol-Myers Squibb Company Substituted dihydropyrimidine inhibitors of calcium channel function
DE10342503A1 (de) * 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
US7504431B2 (en) 2004-04-16 2009-03-17 Bristol-Myers Squibb Company Sulfonyl amide inhibitors of calcium channel function
EP2308852A1 (de) 2005-08-21 2011-04-13 Abbott GmbH & Co. KG 5-Ring-Heteroaromaten-Verbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren
GB0715103D0 (en) * 2007-08-03 2007-09-12 Lectus Therapeutics Ltd Calcium ion channel modulators and uses thereof
US10501421B1 (en) * 2017-01-27 2019-12-10 Vanderbilt University Substituted benzimidazoles as modulators of Ras signaling
JP2023538326A (ja) * 2020-08-11 2023-09-07 ボード オブ トラスティーズ オブ ミシガン ステイト ユニバーシティ プロテアソームエンハンサ及びその使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004016A (en) * 1975-08-11 1977-01-18 E. R. Squibb & Sons, Inc. Amino-benzimidazole derivatives
CA2009542C (en) * 1989-02-10 2000-03-14 Albert A. Carr Cyclic guanidines as calcium antagonists
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5210091A (en) * 1991-06-24 1993-05-11 Neurosearch A/S Imidazole compounds and their use

Also Published As

Publication number Publication date
NO924646L (no) 1993-06-04
FI925501A (fi) 1993-06-04
JPH072796A (ja) 1995-01-06
ATE134622T1 (de) 1996-03-15
KR100220303B1 (ko) 1999-09-15
NO300832B1 (no) 1997-08-04
AU649899B2 (en) 1994-06-02
US5314903A (en) 1994-05-24
EP0545845A1 (en) 1993-06-09
DK0545845T3 (da) 1996-08-05
ES2084972T3 (es) 1996-05-16
GR3019439T3 (en) 1996-06-30
DE69208604D1 (de) 1996-04-04
CA2084233A1 (en) 1993-06-04
EP0545845B1 (en) 1996-02-28
NZ245287A (en) 1995-04-27
AU2965192A (en) 1993-06-10
NO924646D0 (no) 1992-12-02
DE69208604T2 (de) 1996-09-05
FI925501A0 (fi) 1992-12-03

Similar Documents

Publication Publication Date Title
FI935801A (fi) Imidatsoliyhdisteitä, niiden valmistus ja käyttö
ZA929268B (en) Imidazole compounds, their preparation and use.
CA2285891A1 (en) Triazole antifungal agents
SG48939A1 (en) Azole compounds their production and use
DE69505470D1 (de) Pyrrolocarbazol
AU546388B2 (en) ;het;-substituted-3-triazolylpropanes
DE69302087D1 (de) Trazodone alkyl derivate mit zns wirkung
ZA919564B (en) Astaxanthin intermediates